The association of vascular proliferation with HPV status and epithelial PCNA positivity in cervical intraepithelial lesions

APMIS

Volumn 104, Issue 3, 1996, Pages 183-190

  Soini, Ylermi ^a   Pöllänen, Raimo ^b   Kemppainen, Sari ^b   Pääkkö, Paavo ^b   Lehto, Veli Pekka ^b  

^a UNIVERSITY OF OULU   (Finland)

^b NONE

Author keywords

Angiogenesis; Cervix; Dysplasia; p53; PCNA

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY KI 67; PROTEIN P53;

ANGIOGENESIS; ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; WART VIRUS;

EID: 0029870035     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1996.tb00706.x     Document Type: Article

References (22)

1. Baserga, R.: Growth regulation of the PCNA gene. J. Cell Sci. 98: 433-436, 1991.
2. Dameron, K. M., Volpert, O. V., Tainsky, M. A. & Bouck, N. P.: Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584, 1994.
3. De Villiers, E.-M.: Heterogeneity of human papillomavirus group. J. Virol. 6: 4898-4903, 1989.
4. Demeter, L. M., Stoler, M. H., Broker, T. R. & Chow, L. T.: Induction of proliferating cell nuclear antigen in differentiated keratinocytes of human papilloma-infected lesions. Hum. Pathol. 25: 343-348, 1994.
5. Karakitsos, P., Kyroudes, A., Apostolaki, C. et al.: The evaluation of PCN A/cyclin expression in cervical intraepithelial lesions. Gynecol. Oncol. 55: 101-107, 1994.
6. Korkolopoulou, P., Pat souris, E., Pangalis, G. et al.: A comparative assessment of proliferating cell nuclear antigen, c-myc, p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases. Hum. Pathol. 24: 371-377, 1993.
7. Mittal, K. R., Demopoulos, R. I. & Goswami, S.: Proliferating cell nuclear antigen (cyclin) expression in normal and abnormal cervical squamous epithelia. Am. J. Surg. Pathol. 17: 117-122, 1993.
8. Munger, K., Scheffner, M., Huibregtse, J. M. & Howley, P. M.: Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. Cancer Surv. 12: 197-217, 1992.
9. Pöllänen, R., Vuopala, S. & Lehto, V.-P.: Detection of human papillomavirus infection by non-isotopic in situ hybridization in condylomatous and CIN lesions. J. Clin. Pathol. 46: 936-939, 1993.
10. Ranki, M., Leinonen, A. W., Jalava, T. et al.: Use of Affiprobe kit for detection of human papillomavirus DNA in genital scrapes. J. Clin. Microbiol. 28: 2076-2081, 1990.
11. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. & Howley, P. M.: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136, 1990.
12. Shurbaji, M. S., Brooks, S. K. & Thurmond, T. S.: Proliferating cell nuclear antigen immunoreactivity in cervical intraepithelial neoplasia and benign cervical epithelium. Am. J. Clin. Pathol. 100: 22-26, 1993.
13. Skopelitou, A., Korkolopoulou, P., Papanicolaou, A., Christodoulou, P., Thomas-Tsagli, E. & Pavlakis, K.: Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters. Eur. Urol. 22: 235-240. 1992.
14. Smith-McCune, K. K. & Weidner, N.: Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res. 54: 800-804, 1994.
15. Soini, Y., Pääkkö, P., Nuorva, K., Kamel, D., Lane, D. & Vähäkangas, K.: Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas. Virchows Arch. A 421: 223-338, 1992.
16. Syrjänen, S.: Basic concepts and practical applications of recombinant DNA techniques in detection of human papillomavirus (HPV) infections. APMIS 98: 95-100, 1990.
17. Tahan, S. R., Neuberg, D. S., Dieffenbach, A. & Yacoub, L.: Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score. Cancer 71: 3552-3559, 1993.
18. Volkman, J.: Angiogenesis in cancer, vascular, rheumatoid and other disease. A review. Nature Medicine 1: 27-31, 1995.
19. Waga, S., Hannon, G. J., Beach, D. & Stillman, B.: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578, 1994.
20. Werness, B. A., Levine, A. J. & Howley, P. M.: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79, 1990.
21. 2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology 19: 21-27, 1991.
22. Zur Hausen, H.: Papillomavirus/Host cell interactions in the pathogenesis of anogenital cancer. In: Origins of Human Cancer: A comprehensive review. Cold Spring Harbor Laboratory Press. New York 1991, pp. 685-705.